$INO Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800 is fully enrolled with all 40 healthy volunteers receiving their first dose, with interim immune responses and safety results expected in late June. 
$APT $TNXP $BTC $IBIO $SPOM $CODX $AIM $ALT  $RTTR  $AYTU $AAPL